Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes

Journal of Internal Medicine

Volumn 269, Issue 2, 2011, Pages 189-199

  Kacerovsky, M ^a   Brehm, A ^a   Chmelik, M ^a,b   Schmid, A I ^a,b   Szendroedi, J ^a,c,d   Kacerovsky Bielesz, G ^a   Nowotny, P ^c   Lettner, A ^a   Wolzt, M ^b   Jones, J G ^e   Roden, M ^a,c,d  

^a HANUSCH HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Energy metabolism; Glucose transport; Glycaemic control; Insulin therapy; Oxidative phosphorylation

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; GLUCOSE 6 PHOSPHATE; HEMOGLOBIN A1C; INSULIN; LIPID;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MUSCLE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FASTING; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN RESISTANCE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; YOUNG ADULT;

EID: 78651069103     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02298.x     Document Type: Article

References (52)

1. Cline GW, Magnusson I, Rothman DL, Petersen KF, Laurent D, Shulman GI. Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus. J Clin Invest 1997; 99: 2219-24.
2. Szendroedi J, Roden M. Mitochondrial fitness and insulin sensitivity in humans. Diabetologia 2008; 51: 2155-67.
3. Szendroedi J, Schmid AI, Meyerspeer M et al. Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes. Diabetes Care 2009; 32: 677-9.
4. Szendroedi J, Schmid AI, Chmelik M et al. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 2007; 4: e154.
5. Petersen KF, Dufour S, Shulman GI. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med 2005; 2: e233.
6. Petersen KF, Befroy D, Dufour S et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003; 300: 1140-2.
7. Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhausl W, Roden M. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 2006; 55: 136-40.
8. Szendroedi JSA, Meyerspeer M, Cervin C et al. Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes. Diabetes Care 2009; 32: 677-9.
9. Moller HE, Wiedermann D, Kurlemann G, Hilbich T, Schuierer G. Application of NMR spectroscopy to monitoring MELAS treatment: a case report. Muscle Nerve 2002; 25: 593-600.
10. Fasching P, Ratheiser K, Damjancic P et al. Both acute and chronic near-normoglycaemia are required to improve insulin resistance in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 346-51.
11. Rossetti L. Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus. Clin Invest Med 1995; 18: 255-60.
12. Perseghin G, Lattuada G, Danna M et al. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 2003; 285: E1174-81.
13. Karakelides H, Asmann YW, Bigelow ML et al. Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects. Diabetes 2007; 56: 2683-9.
14. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936-42.
15. Brown TR, Ugurbil K, Shulman RG. 31P nuclear magnetic resonance measurements of ATPase kinetics in aerobic Escherichia coli cells. Proc Natl Acad Sci U S A 1977; 74: 5551-3.
16. Brindle KM, Blackledge MJ, Challiss RA, Radda GK. 31P NMR magnetization-transfer measurements of ATP turnover during steady-state isometric muscle contraction in the rat hind limb in vivo. Biochemistry 1989; 28: 4887-93.
17. Jucker BM, Dufour S, Ren J et al. Assessment of mitochondrial energy coupling in vivo by 13C/31P NMR. Proc Natl Acad Sci U S A 2000; 97: 6880-4.
18. Lebon V, Dufour S, Petersen KF et al. Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest 2001; 108: 733-7.
19. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 664-71.
20. Forsén S, Huffman RA. Study of moderatly rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys 1963; 39: 2892-901.
21. Meyerspeer M, Krssak M, Moser E. Relaxation times of 31P-metabolites in human calf muscle at 3 T. Magn Reson Med 2003; 49: 620-5.
22. Gadian DG, Radda GK, Brown TR, Chance EM, Dawson MJ, Wilkie DR. The activity of creatine kinase in frog skeletal muscle studied by saturation-transfer nuclear magnetic resonance. Biochem J 1981; 194: 215-28.
23. Harris RC, Hultman E, Nordesjo LO. Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand J Clin Lab Invest 1974; 33: 109-20.
24. Krebs M, Krssak M, Nowotny P et al. Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humans. J Clin Endocrinol Metab 2001; 86: 2153-60.
25. Roden M, Shulman GI. Applications of NMR spectroscopy to study muscle glycogen metabolism in man. Annu Rev Med 1999; 50: 277-90.
26. Kemp GJ, Meyerspeer M, Moser E. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review. NMR Biomed 2007; 20: 555-65.
27. Anderwald C, Bernroider E, Krssak M et al. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 2002; 51: 3025-32.
28. Naressi A, Couturier C, Devos JM et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001; 12: 141-52.
29. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997; 129: 35-43.
30. Pang TT, Narendran P. Addressing insulin resistance in Type 1 diabetes. Diabet Med 2008; 25: 1015-24.
31. Ma X, Becker D, Arena VC, Vicini P, Greenbaum C. The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of type 1 diabetic patients: a population analysis. J Clin Endocrinol Metab 2009; 94: 2446-51.
32. Asmann YW, Stump CS, Short KR et al. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 2006; 55: 3309-19.
33. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci U S A 2003; 100: 7996-8001.
34. Gale EA. To boldly go - or to go too boldly? The accelerator hypothesis revisited. Diabetologia 2007; 50: 1571-5.
35. Cline GW, Petersen KF, Krssak M et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 1999; 341: 240-6.
36. Ng JM, Kelley DE, Goodpaster BH. Mechanisms of insulin resistance assessed by dynamic in-vivo positron emission tomography imaging. Curr Opin Clin Nutr Metab Care 2009; 12: 508-12.
37. Liu HY, Cao SY, Hong T, Han J, Liu Z, Cao W. Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM). J Biol Chem 2009; 284: 27090-100.
38. Crowther GJ, Milstein JM, Jubrias SA, Kushmerick MJ, Gronka RK, Conley KE. Altered energetic properties in skeletal muscle of men with well-controlled insulin-dependent (type 1) diabetes. Am J Physiol Endocrinol Metab 2003; 284: E655-62.
39. Roden M, Krssak M, Stingl H et al. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 1999; 48: 358-64.
40. Krebs M, Brehm A, Krssak M et al. Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia 2003; 46: 917-25.
41. Battezzati A, Terruzzi I, Perseghin G et al. Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma. Diabetes 1995; 44: 837-44.
42. Cederholm T, Sylven C, Esbjornsson-Liljedahl M, Jansson E. Insulin treatment increases skeletal muscle fibre area in patients with diabetes mellitus type 2. Clin Physiol 2000; 20: 354-9.
43. Wallberg-Henriksson H, Gunnarsson R, Henriksson J et al. Increased peripheral insulin sensitivity and muscle mitochondrial enzymes but unchanged blood glucose control in type I diabetics after physical training. Diabetes 1982; 31: 1044-50.
44. Wallberg-Henriksson H, Gunnarsson R, Henriksson J, Ostman J, Wahren J. Influence of physical training on formation of muscle capillaries in type I diabetes. Diabetes 1984; 33: 851-7.
45. Tessari P, Nosadini R, Trevisan R et al. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism. J Clin Invest 1986; 77: 1797-804.
46. Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R. Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 2008; 57: 56-63.
47. Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 1983; 25: 400-3.
48. Hagstrom-Toft E, Bolinder J, Ungerstedt U, Arner P. A circadian rhythm in lipid mobilization which is altered in IDDM. Diabetologia 1997; 40: 1070-8.
49. Kacerovsky-Bielesz G, Chmelik M, Ling C et al. Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes. Diabetes 2009; 58: 1333-41.
50. Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-53.
51. El-Osta A, Brasacchio D, Yao D et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008; 205: 2409-17.
52. Abdul-Ghani MA, Jani R, Chavez A, Molina-Carrion M, Tripathy D, Defronzo RA. Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants. Diabetologia 2009; 52: 574-82.